NCT06353672 A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
| NCT ID | NCT06353672 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhejiang University |
| Condition | Liver Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-12-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2020-12-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The robotic surgery system, the most advanced technology in minimally invasive surgery, overcame some shortcomings of laparoscopic surgery and improved the flexibility and precision of liver resection. Several studies have demonstrated that the robotic system was safe and feasible in liver surgery and might be advantageous in complex hepatic vein and hilar dissection, operative bleeding control, and biliary reconstruction. Previous comparative studies found limited evidence for significantly improved outcomes in robotic liver resection (RLR) over laparoscopic liver resection (LLR) or open liver resection (OLR), considering the various degrees of difficulty in liver surgeries. This study aimed to evaluate safety and feasibility of robotic liver resection, by comparing it with LLR or OLR, and gain veritable and relevant data on the benefits of RLR.
Eligibility Criteria
Inclusion Criteria: * The patients were diagnosed with a liver tumor. * The patients underwent robotic liver resection. Exclusion Criteria: * The patients underwent simultaneous malignancy resection of the colorectum or other organs (except gallbladder).
Frequently Asked Questions
Who can join the NCT06353672 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Liver Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06353672 currently recruiting?
Yes, NCT06353672 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zhejiang University to inquire about joining.
Where is the NCT06353672 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06353672 clinical trial?
NCT06353672 is sponsored by Zhejiang University. The trial plans to enroll 1,000 participants.